Authors:
PEGHINI PA
ZAHNER R
KUSTER H
SCHOTT H
SCHWENDENER RA
Citation: Pa. Peghini et al., IN-VITRO ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS AND ANTI-HEPATITIS-B VIRUSACTIVITIES AND PHARMACOKINETIC PROPERTIES OF HETERODINUCLEOSIDE PHOSPHATES CONTAINING AZT OR DDC, Antiviral chemistry & chemotherapy, 9(2), 1998, pp. 117-126
Citation: H. Schott, COMPARING THE SURFACE CHEMICAL-PROPERTIES AND THE EFFECT OF SALTS ON THE CLOUD POINT OF A CONVENTIONAL NONIONIC SURFACTANT, OCTOXYNOL-9 (TRITON X-100), AND OF ITS OLIGOMER, TYLOXAPOL (TRITON WR-1339), Journal of colloid and interface science (Print), 205(2), 1998, pp. 496-502
Authors:
SCHOTT H
LUDWIG PS
GANSAUGE F
GANSAUGE S
SCHWENDENER RA
Citation: H. Schott et al., SYNTHESIS AND IN-VITRO ANTITUMOR-ACTIVITY OF -(3'-]-5')-2'-DEOXY-5-FLUORO-N-4-OCTADECYLCYTIDINE - A NEW AMPHIPHILIC DINUCLEOSIDE PHOSPHATE, Liebigs Annalen, (2), 1997, pp. 413-417
Citation: H. Schott, SIMILARITY BETWEEN THE CLOUDING OF NONIONIC SURFACTANTS AND THE DENATURATION OF BIOPOLYMERS, AND THE EFFECT OF ANIONS ON BOTH PHENOMENA - EFFECT OF INORGANIC ADDITIVES ON SOLUTIONS OF NONIONIC SURFACTANTS .8., Tenside, surfactants, detergents, 34(5), 1997, pp. 304
Citation: H. Schott, DE-CLAVICORDIO-II - PROCEEDINGS OF THE INTERNATIONAL-CLAVICHORD-SYMPOSIUM, MAGNANO, 21-23 SEPTEMBER 1995 - BRAUCHLI,B, BRAUCHLI,S, CRALAZZO,A, Notes, 54(1), 1997, pp. 74-75
Authors:
RENTSCH KM
SCHWENDENER RA
SCHOTT H
HANSELER E
Citation: Km. Rentsch et al., PHARMACOKINETICS OF N-4-OCTADECYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PLASMA AND WHOLE-BLOOD AFTER INTRAVENOUS AND ORAL-ADMINISTRATION TO MICE, Journal of Pharmacy and Pharmacology, 49(11), 1997, pp. 1076-1081
Citation: Skm. Kollerlucae et al., INTERACTIONS WITH HUMAN BLOOD IN-VITRO AND PHARMACOKINETIC PROPERTIESIN MICE OF LIPOSOMAL N-4-OCTADECYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE,A NEW ANTICANCER DRUG, The Journal of pharmacology and experimental therapeutics, 282(3), 1997, pp. 1572-1580
Citation: H. Schott, EFFECT OF INORGANIC ADDITIVES ON SOLUTIONS OF NONIONIC SURFACTANTS .15. EFFECT OF TRANSITION-METAL SALTS ON THE CLOUD POINT OF OCTOXYNOL-9 (TRITON X-100), Journal of colloid and interface science, 192(2), 1997, pp. 458-462
Citation: H. Schott, EFFECT OF INORGANIC ADDITIVES ON SOLUTIONS OF NONIONIC SURFACTANTS .14. EFFECT OF CHAOTROPIC ANIONS ON THE CLOUD POINT OF OCTOXYNOL-9 (TRITON X-100), Journal of colloid and interface science, 189(1), 1997, pp. 117-122
Authors:
SMITH JM
MEYERS KM
BARBEE DD
SCHOTT H
BAYLY WM
Citation: Jm. Smith et al., PLASMA VON-WILLEBRAND-FACTOR IN THOROUGHBREDS IN RESPONSE TO HIGH-INTENSITY TREADMILL EXERCISE, American journal of veterinary research, 58(1), 1997, pp. 71-76
Citation: H. Schott et Ra. Schwendener, SYNTHESIS OF LIPOSOMAL (N-4-PALMITOYL-1-BETA-D-ARABINOFURANOSYL-CYTOSINE) CONJUGATES AND EVALUATION OF THEIR CYTOSTATIC ACTIVITY AGAINST L1210 MURINE LEUKEMIA, Liebigs Annalen, (3), 1996, pp. 365-369
Citation: H. Schott, EFFECT OF ELECTROLYTES AND PROTEIN DENATURANTS ON NONIONIC SURFACTANTS - A SURVEY OF THE EFFECT OF ELECTROLYTES AND PROTEIN DENATURANTS ON CLOUD POINTS AND KRAFFT POINTS OF NONIONIC SURFACTANTS, Tenside, surfactants, detergents, 33(6), 1996, pp. 457-463
Citation: H. Schott et Ra. Schwendener, SYNTHESIS AND STRUCTURE-ACTIVITY STUDIES IN-VIVO OF LIPOSOMAL ID-N-4-PALMITOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE AND N-4-HEXADECYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE CONJUGATES, Anti-cancer drug design, 11(6), 1996, pp. 451-462
Authors:
SCHWENDENER RA
HORBER DH
ODERMATT B
SCHOTT H
Citation: Ra. Schwendener et al., ORAL ANTITUMOR-ACTIVITY IN MURINE L1210 LEUKEMIA AND PHARMACOLOGICAL PROPERTIES OF LIPOSOME FORMULATIONS OF N-4-ALKYL DERIVATIVES OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE, Journal of cancer research and clinical oncology, 122(2), 1996, pp. 102-108
Citation: Ra. Schwendener et H. Schott, LIPOPHILIC 1-BETA-D-ARABINOFURANOSYL CYTOSINE DERIVATIVES IN LIPOSOMAL FORMULATIONS FOR ORAL AND PARENTERAL ANTILEUKEMIC THERAPY IN THE MURINE L1210 LEUKEMIA MODEL, Journal of cancer research and clinical oncology, 122(12), 1996, pp. 723-726